225:
867:
396:
24:
924:
472:
687:
404:
376:
680:
673:
485:
508:
968:
908:
274:
1017:
823:
961:
901:
808:
239:
1022:
997:
609:
954:
446:
894:
108:
492:
432:
182:
840:
203:
395:
992:
139:
773:
828:
797:
987:
665:
418:
388:
36:
733:
722:
220:
1012:
1007:
934:
579:
571:
442:
66:
866:
575:
1002:
630:
520:
128:
938:
878:
648:
874:
713:
700:
360:
297:
76:
191:
83:
613:
224:
834:
555:
528:
463:
531:; a side effect was increased body hair. Both compounds have been used for therapy of
981:
748:
603:
349:
171:
454:
763:
704:
697:
653:
438:
23:
931:
758:
753:
742:
535:. Kopexil is not approved for use as a drug in the United States or in Europe.
923:
328:
119:
787:
782:
524:
634:
559:
551:
532:
544:
158:
140:
462:
Except where otherwise noted, data are given for materials in their
424:
627:
Status of scalp hair and therapy of alopecia in men in
Switzerland
107:
97:
669:
450:
208:
354:
210 to 218 °C (410 to 424 °F; 483 to 491 K)
248:
InChI=1S/C4H6N4O/c5-3-1-2-7-4(6)8(3)9/h1-2H,5H2,(H2,6,7)
942:
882:
480:
796:
772:
732:
712:
258:
InChI=1S/C4H6N4O/c5-3-1-2-7-4(6)8(3)9/h1-2,6,9H,5H2
170:
649:Haarerkrankungen in der dermatologischen Praxis
82:
75:
527:. Minoxidil was originally used to treat high
40:2,3-Dihydro-3-hydroxy-2-imino-4-pyrimidinamine
962:
902:
681:
8:
574:of kopexil is unknown. There is no proof of
558:is oxidized. The compound can exist in two
969:
955:
909:
895:
688:
674:
666:
223:
127:
15:
190:
599:
597:
595:
591:
279:
244:
219:
550:, a group of substances in which the
261:Key: YTKGAYFHUZTLCI-UHFFFAOYSA-N
251:Key: SGHQFNHCCOBUKB-UHFFFAOYSA-N
7:
920:
918:
863:
861:
161:
941:. You can help Knowledge (XXG) by
881:. You can help Knowledge (XXG) by
605:MSDS for Kopexil at Kumar Organics
14:
922:
865:
470:
394:
315:
309:
22:
466:(at 25 °C , 100 kPa).
87: (pyridine oxide tautomer)
321:
303:
1:
1018:Antihypertensive agent stubs
1039:
917:
860:
818:
774:Potassium channel openers
460:
375:
370:
290:
270:
235:
59:
51:
35:
30:
21:
798:Calcium channel blockers
716:(arterioles and venules)
625:Trüeb RM, de Viragh PA:
433:Precautionary statements
344:white odorless crystals
42:2,4-Diaminopyrimidine 3-
1023:Dermatologic drug stubs
998:Antihypertensive agents
513:diaminopyrimidine oxide
877:-related article is a
734:Hydrazinophthalazines
578:for kopexil against
572:mechanism of action
566:Mechanism of action
361:Solubility in water
336: g·mol
18:
845:Never to phase III
612:2015-07-22 at the
576:therapeutic effect
539:Chemical structure
493:Infobox references
16:
950:
949:
890:
889:
855:
854:
701:antihypertensives
696:Nonsympatholytic
521:chemical compound
501:Chemical compound
499:
498:
419:Hazard statements
366:slightly soluble
204:CompTox Dashboard
109:Interactive image
1030:
993:Aminopyrimidines
971:
964:
957:
926:
919:
911:
904:
897:
875:antihypertensive
869:
862:
714:Nitrovasodilator
690:
683:
676:
667:
657:
644:
638:
623:
617:
616:March 28th 2012.
601:
483:
477:
474:
473:
456:
452:
448:
444:
440:
426:
398:
335:
323:
317:
311:
305:
298:Chemical formula
228:
227:
212:
210:
194:
174:
163:
142:
131:
111:
86:
79:
26:
19:
1038:
1037:
1033:
1032:
1031:
1029:
1028:
1027:
978:
977:
976:
975:
916:
915:
858:
856:
851:
850:
835:Clinical trials
814:
792:
768:
728:
708:
694:
663:
661:
660:
646:Wolfgang Raab:
645:
641:
624:
620:
614:Wayback Machine
602:
593:
588:
568:
541:
502:
495:
490:
489:
488: ?)
479:
475:
471:
467:
435:
421:
407:
391:
363:
333:
320:
314:
308:
300:
286:
283:
278:
277:
266:
263:
262:
259:
253:
252:
249:
243:
242:
231:
213:
206:
197:
177:
164:
152:
134:
114:
101:
90:
69:
55:
47:
41:
12:
11:
5:
1036:
1034:
1026:
1025:
1020:
1015:
1010:
1005:
1000:
995:
990:
980:
979:
974:
973:
966:
959:
951:
948:
947:
927:
914:
913:
906:
899:
891:
888:
887:
870:
853:
852:
849:
848:
847:
846:
843:
832:
826:
820:
819:
816:
815:
813:
812:
803:
801:
794:
793:
791:
790:
785:
779:
777:
770:
769:
767:
766:
761:
756:
751:
746:
739:
737:
730:
729:
727:
726:
719:
717:
710:
709:
695:
693:
692:
685:
678:
670:
659:
658:
639:
618:
590:
589:
587:
584:
567:
564:
556:tertiary amine
543:Kopexil is an
540:
537:
529:blood pressure
500:
497:
496:
491:
469:
468:
464:standard state
461:
458:
457:
436:
431:
428:
427:
422:
417:
414:
413:
408:
403:
400:
399:
392:
387:
384:
383:
373:
372:
368:
367:
364:
359:
356:
355:
352:
346:
345:
342:
338:
337:
331:
325:
324:
318:
312:
306:
301:
296:
293:
292:
288:
287:
285:
284:
281:
273:
272:
271:
268:
267:
265:
264:
260:
257:
256:
254:
250:
247:
246:
238:
237:
236:
233:
232:
230:
229:
221:DTXSID40996155
216:
214:
202:
199:
198:
196:
195:
187:
185:
179:
178:
176:
175:
167:
165:
157:
154:
153:
151:
150:
146:
144:
136:
135:
133:
132:
124:
122:
116:
115:
113:
112:
104:
102:
95:
92:
91:
89:
88:
80:
72:
70:
65:
62:
61:
57:
56:
53:
49:
48:
39:
33:
32:
28:
27:
13:
10:
9:
6:
4:
3:
2:
1035:
1024:
1021:
1019:
1016:
1014:
1011:
1009:
1006:
1004:
1001:
999:
996:
994:
991:
989:
986:
985:
983:
972:
967:
965:
960:
958:
953:
952:
946:
944:
940:
937:article is a
936:
933:
928:
925:
921:
912:
907:
905:
900:
898:
893:
892:
886:
884:
880:
876:
871:
868:
864:
859:
844:
842:
839:
838:
836:
833:
830:
827:
825:
822:
821:
817:
811:
810:
805:
804:
802:
799:
795:
789:
786:
784:
781:
780:
778:
775:
771:
765:
762:
760:
757:
755:
752:
750:
749:Dihydralazine
747:
744:
741:
740:
738:
735:
731:
724:
723:Nitroprusside
721:
720:
718:
715:
711:
706:
702:
699:
691:
686:
684:
679:
677:
672:
671:
668:
664:
655:
651:
650:
643:
640:
636:
632:
628:
622:
619:
615:
611:
608:
606:
600:
598:
596:
592:
585:
583:
581:
577:
573:
565:
563:
561:
557:
553:
549:
547:
538:
536:
534:
530:
526:
522:
518:
515:, trade name
514:
510:
506:
494:
487:
482:
465:
459:
437:
434:
430:
429:
423:
420:
416:
415:
412:
409:
406:
402:
401:
397:
393:
390:
386:
385:
381:
379:
374:
369:
365:
362:
358:
357:
353:
351:
350:Melting point
348:
347:
343:
340:
339:
332:
330:
327:
326:
302:
299:
295:
294:
289:
282:c1cnc((c1N))N
280:
276:
269:
255:
245:
241:
234:
226:
222:
218:
217:
215:
205:
201:
200:
193:
189:
188:
186:
184:
181:
180:
173:
169:
168:
166:
160:
156:
155:
148:
147:
145:
143:
138:
137:
130:
126:
125:
123:
121:
118:
117:
110:
106:
105:
103:
99:
94:
93:
85:
81:
78:
74:
73:
71:
68:
64:
63:
58:
50:
45:
38:
34:
29:
25:
20:
988:Amine oxides
943:expanding it
932:dermatologic
929:
883:expanding it
872:
857:
806:
800:(arterioles)
776:(arterioles)
764:Pildralazine
736:(arterioles)
698:vasodilatory
662:
654:Google Books
652:, p. 82, at
647:
642:
626:
621:
604:
569:
545:
542:
516:
512:
504:
503:
410:
377:
60:Identifiers
52:Other names
43:
831:from market
759:Cadralazine
754:Endralazine
743:Hydralazine
523:similar to
405:Signal word
341:Appearance
291:Properties
77:113275-13-1
37:IUPAC names
1013:Human hair
1008:Guanidines
982:Categories
586:References
570:The exact
560:tautomeric
554:atom of a
389:Pictograms
329:Molar mass
192:1756681479
120:ChemSpider
96:3D model (
84:74638-76-9
67:CAS Number
841:Phase III
829:Withdrawn
788:Diazoxide
783:Minoxidil
656:(German).
525:minoxidil
447:P301+P312
380:labelling
149:616-121-2
141:EC Number
1003:Enamines
635:11256223
610:Archived
580:alopecia
552:nitrogen
533:alopecia
517:Aminexil
371:Hazards
172:10197687
129:10445922
54:Aminexil
17:Kopexil
562:forms.
519:) is a
505:Kopexil
486:what is
484: (
411:Warning
334:126.119
159:PubChem
824:WHO-EM
633:
548:-oxide
481:verify
478:
275:SMILES
46:-oxide
31:Names
930:This
873:This
511:name
240:InChI
98:JSmol
939:stub
935:drug
879:stub
809:list
807:see
631:PMID
509:INCI
455:P501
451:P330
443:P270
439:P264
425:H302
183:UNII
705:C02
378:GHS
209:EPA
162:CID
984::
837::
629:;
594:^
582:.
453:,
449:,
445:,
441:,
382::
970:e
963:t
956:v
945:.
910:e
903:t
896:v
885:.
745:#
725:#
707:)
703:(
689:e
682:t
675:v
637:.
607:.
546:N
507:(
476:Y
322:O
319:4
316:N
313:6
310:H
307:4
304:C
211:)
207:(
100:)
44:N
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
